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Abstract: Chemical cell surface engineering is a tool for modifying 
and altering cellular functions. Herein we report the introduction of 
an antibiotic phenotype to the green alga Chlamydomonas 
reinhardtii by chemically modifying its cell surface. Flow cytometry 
and confocal microscopy studies demonstrated that a hybrid of the 
antibiotic vancomycin and a 4-hydroxyproline oligomer binds 
reversibly to the cell wall without affecting the viability and motility of 
the cells. The modified cells were used to inhibit bacterial growth of 
Gram-positive Bacillus subtilis cultures. Delivery of the antibiotic 
form the microalgae to the bacterial cells is supported by microscopy. 
Our studies provide compelling evidence that (a) chemical surface 
engineering constitutes a useful tool for the introduction of new, 
previously unknown functionality, and that (b) living microalgae can 
serve as new platforms for drug delivery. 
Over recent decades, cell surface engineering has emerged as 
a key technology for regulating cellular communication and at 
the same time altering fundamental functions. In particular, two 
main approaches to achieving this goal constitute genetic[1] or 
metabolic surface engineering[2] both using the biosynthetic 
machinery of the cell. In the first case, modification of the 
genetic code leads to the expression of a protein epitope on the 
cell surface (see Figure 1). On the other hand, metabolic 
engineering involves feeding the cells with modified monomers 
for cell surface biosynthesis that can be functionalized later 
using bio-orthogonal chemistry.[3] Both techniques are 
permanent and in the case of genetic expression also hereditary. 
More recently, a chemical approach to this fundamental 
challenge has been developed using exogenous materials that 
interact with the outer parts of the cell surface allowing a more 
controlled, non-permanent and non-genetic manner to 
functionalize cell walls.[4] These techniques involve the direct 
reaction of functional materials with amine or thiol groups on the 
cell surface[5], hydrophobic materials inserting into cell 
membranes[6], materials attached by electrostatic interactions, [7] 
and others.[8] 
Microalgae are multifunctional living materials that have been 
used in numerous applications such as CO2-fixation for 
production of biodiesel[9] and food ingredients,[10] as well as 
oxygen producers in wound healing.[11] However, their utilization 
as drug delivery systems has been much less explored. 
Whereas biopolymers of microalgae have been recognized to be 
materials for drug delivery,[12] the potential for entire, non-
genetically modified, and living cells as agents for drug delivery 
has not yet been investigated to the best of our knowledge. The 
only examples published so far involve dead, genetically 
engineered diatom silica for the delivery of anti-cancer agents[13] 
and genetically engineered green algae for the production of 
immunotoxin anticancer therapeutics.[14] We therefore 
hypothesize whether living microalgae could be directly used for 
drug delivery applications employing chemical surface 
engineering instead of genetic engineering approaches. 
In this study, we report the functionalization of the green alga 
Chlamydomonas reinhardtii using chemical surface engineering 
with an antibiotic hybrid. The resulting modified algae have been 
shown to kill Gram-positive bacteria, thereby delivering the 
antibiotic from the algae to the target pathogen.  
Figure 1: Functionalization of C. reinhardtii with an antibiotic hybrid can be 
used to fight Gram-positive bacteria. 
The microalga C. reinhardtii serves as a model organism for the 
study of fundamental processes in biology.[15] This eukaryotic 
unicellular phototroph comprises two flagella, which control 
motility via phototactic responses.[16] In the past, it has therefore 
been utilized as a molecular motor to transport polymer beads 
through microfluidic channels.[17] The beads were attached to the 
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cell wall using a 4-hydroxyproline oligomer by non-covalent 
interactions with the glycopeptides of the cell wall of C. 
reinhardtii. For the functionalization of the algal cell wall, we 
envisioned a hybrid of the oligoproline anchor and an antibiotic. 
To this goal, we chose vancomycin, a glycopeptide highly active 
against Gram-positive bacteria, and which had previously been 
used successfully by us for the functionalization of TiO2 
surfaces.[18] Based on these design principles, we engineered 
the target vancomycin hybrid 1, which displays high water 
solubility and fluorescent properties (Figure 1). Its preparation 
involved a combination of solid-phase and solution-phase 
peptide synthesis techniques (see supporting information). 
Figure 2: The target hybrid 1 connecting the antibiotic vancomycin with a 
oligohydroxyproline anchor containing a fluorophore for in vivo cell imaging. 
First, we investigated the attachment of hybrid 1 to the surface 
of C. reinhardtii. Algae cells were incubated in a solution of 1 (1 
µmol/mL) in algae medium for 12 h. The cells were washed and 
inspected with a confocal fluorescent microscope. As 
hypothesized, compound 1 adhered strongly to the algal cells in 
the presence of excess of 1. We observed attachment of the 
compound primarily to the surface but we also detected 
internalization of the hybrid (Figure 3f). Attachment of the 
compound 1 and viability of the cells were strongly dependent 
on the incubation time and concentration. High concentrations of 
construct 1 (4.5 µmol/mL) led to immediate disruption of motility 
and resulted in strong internalization of substance. However, 
when concentration, incubation time and cell density were 
carefully optimized, viability and motility of the cells were fully 
maintained.[19] As evidence for the successful attachment of 
vancomycin derivative 1 with retained cell viability, we performed 
flow cytometry measurements with untreated and modified cells. 
The cells were analyzed by detection of fluorescein for the 
presence of fluorescently labelled 1 and the cells were subjected 
to propidium iodide prior to the flow cytometry measurement. 
Propidium iodide is a nuclei-staining dye and penetrates only 
through disrupted areas of cell walls thereby labelling only dead 
cells.[20] While untreated cells acting as a negative control did not 
reveal any green fluorescence (Figure 3c), these cultures 
contained a minor amount of dead cells (≈13%) that were 
propidium iodide positive (Figure 3d) and are plotted together 
with a control sample of entirely dead cells[21] (blue curve). Algae 
that have been modified with 1 significantly enhanced 
fluorescence (Figure 3g). The smaller population that was 
labelled more intensely than the main population were mostly 
attributed to the dead cells,[22] an effect that is also observed in 
immunofluorescence. The number of propidium iodide positive 
cells (≈12%) did not increase compared to the control of 
unmodified cells (Figure 3h). These results are consistent with 
the previously assessed motility of the cells. We observed that 
incubation of the cells with 4-hydroxyproline oligomers without 
vancomycin (with and without fluorescent label) resulted in cell 
death, an effect that contradicts other cell penetrating cationic 
oligoprolines[23] and needs to be further investigated. We also 
observed that the binding of 1 to the algae cells is reversible and 
allowing the modified cells to stand for 2 days resulted in nearly 
complete release of the compound from the living cells 
(supplementary information Figure S7). We hypothesize that the 
reversible nature of binding is necessary for the delivery of 1 to 
the surface of the bacteria and represents a rare example of 
reversible chemical surface engineering.[24] As a control 
experiment we also attempted the attachment of fluorescently 
labeled vancomycin derivatives[25] using BODIPY and 
fluorescein as fluorophores, however, these experiments were 
challenging because of the drastically reduced water solubility of 
these compounds under the incubation conditions. 
Figure 3: Confocal fluorescence microscopy images and flow cytometry of C. 
reinhardtii after incubation with 1 at a concentration of 1 µmol/mL for 12 h. a, 
Chloroplast of untreated C. reinhardtii. b, No fluorescein fluorescence is 
obtained for untreated C. reinhardtii c, Flow cytometry histogram of untreated 
cells showing no fluorescein fluorescence. d, Flow cytometry histogram of 
untreated cells showing small amounts of dead cells (grey) against a control of 
dead cells (blue). e, Autofluorescence of C. reinhardtii incubated with 1. f, 
Modified cells showed primary localization of 1 on the surface of the algae but 
partly also internalized in the cells. g, Flow cytometry shows quantitative 
modification C. reinhardtii. h, Propidium iodide staining revealed that 
modification with 1 did not result in higher cell death than in the control samle. 
We next evaluated if the modified algal cells carrying the 
vancomycin hybrid 1 were able to kill bacteria. To this goal, the 
effect of the hydroxyproline anchor on the antimicrobial potency 
of vancomycin was examined first. Disk diffusion and MIC 
assays indicated a decrease in activity of hybrid 1 compared to 
vancomycin (∼30x). Reduced activity is likely due to the 
decreased binding ability because of the attached oligoproline 
anchor of 1 to the N-acyl-D-Ala-D-Ala fragment of the target 
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bacterial cell wall.[26] However, the MIC value of 4-8 μg/mL 
demonstrated in general retained activity. We therefore 
proceeded to subjected C. reinhardtii modified with construct 1 
to growing cultures of B. subtilis. Growth of bacteria was 
monitored by the UV-absorption of the cultures at 600 nm 
(OD600).[27] In addition to C. reinhardtii that was previously 
incubated with 1, we also monitored bacterial growth in the 
presence of unmodified algae (positive control) and algae that 
have previously been incubated with vancomycin (Figure 4). For 
lower algae culture densities (Figure 4a, 1.5⋅106 cells/mL) we 
observed a slight inhibition of bacterial growth in the presence of 
modified algae (red) but no inhibition for algae previously 
incubated with vancomycin (grey). When we used more dense 
cultures of C. reinhardtii (Figure 4b, 2.5⋅106 cells/mL) we could 
fully inhibit bacterial growth. We also observed a slight inhibition 
in the control of with vancomycin-incubated algae probably 
resulting from some vancomycin physically adsorbed on the 
surface of C. reinhardtii. However, considering the higher 
antimicrobial potency of vancomycin the amount of vancomycin 
actually adsorbed on the surface is presumably very low in 
comparison to the amount of surface-bound 1.  
Figure 4: Bacterial growth in the presence of unmodified algae (–●–), algae 
that have previously been incubated with 1 (–▲–) and algae previously been 
incubated with vancomycin (–▼–). 6 mL of algae culture was used having a 
density of a, 1.5⋅106 cells/mL and b, 2.5⋅106 cells/mL. 
We wanted to corroborate these growth experiments by directly 
visualizing live and dead cells using fluorescence microscopy. 
Thus, fluorescent staining of the bacterial cultures shown in 
Figure 5b was performed with fluorescent dyes after 6 h of 
incubation in the presence of algae (Figure 5). The two-
component stain allows differentiation between living and dead 
cells by showing the living cells as green and dead cells as red 
fluorescent. Viable bacteria were stained by hydrolysis of the cell 
permeable calcein-AM to calcein that emits the same green 
fluorescence as fluorescein. Dead bacteria were stained with 
propidium iodide that emitted red fluorescence. The stained 
cultures were inspected using a confocal fluorescent microscope. 
For the bacteria grown in the presence of unmodified algae we 
observed a mixture of living and dead cells (Figure 5a-c). This 
can be explained by the fact that bacterial growth had already 
entered stationary phase and some dead cells were present. 
Importantly, the cells either emitted green or red fluorescence 
indicated by the merged image of the red and green channel. 
The bacteria exposed to modified algae showed a matched 
overlay of red and green (Figure 5d-f). The cells present in the 
sample were all propidium iodide positive, which provides strong 
evidence for dead cells. At the same time, bacteria also 
exhibited green fluorescence, which we trace back to the 
fluorescently labeled hybrid 1, that was delivered from the 
modified algae cells to the bacteria. When inspecting a 
magnified single layer image of this sample (Figure 5g-i) the 
distribution of 1 on the bacteria shows that the hybrid primarily 
binds to the cell wall of the bacteria, which is consistent with the 
mode of action of vancomycin. Direct evidence for the stability of 
hybrid 1 during incubation of algae cells and later exposure to B. 
subtilis cultures is not obtained but our experiments show that 
vancomycin is still fluorescently labeled and we presume that 1 
is still intact.  
Figure 5: Staining of bacterial cultures after 6 hours with a live/dead kit. a-c, 
Bacteria grown in the presence of unmodified algae. d-f, Bacteria grown in the 
presence of algae previously modified with 1. g-i, Magnified and single layer 
image of bacteria grown in the presence of algae previously modified with 1.  
Investigations into the mechanism of delivery revealed that 
hybrid 1 is able to partially dissociate from the cell wall of the 
algae into the medium within 1 hour (see supporting information 
Figure S15). This suggests that bacteria and algae do not 
necessarily need physical contact for delivery of 1 but that 1 can 
also be transferred by diffusion.  
In order to test if hybrid 1 binds to the glycopeptides of the algal 
cell wall, we performed incubation experiments with a cell wall-
deficient mutant (supporting information Figure S16). We 
observed significantly less attachment of compound to the cell 
wall-deficient mutant than for the control experiment with the 
wild type. These data suggest that binding of 1 to C. reinhardtii 
is likely due to the non-covalent interaction with the 
glycopeptides present in the cell wall.  
In summary, we have shown that chemical surface engineering 
can be utilized to reversibly functionalize the cell wall of living 
algae. We demonstrated the transformation of microalgae into 
killer cells for Gram-positive bacteria by attachment of an 
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antibiotic to the cell surface of the algae. Binding of the natural 
product hybrid to the algae cells is reversible and the non-
covalent interaction is suggested to take place with the 
glycopeptides present in the cell wall. The viable, modified cells 
were able to deliver the antibiotic to the bacteria and resulted in 
complete inhibition of bacterial growth. Our work opens 
intriguing prospects for further functionalization and utilization of 
microalgae in chemical biology, and potentially, human medicine. 
For further and in-depth evaluation in a therapeutic setting, 
studies are required targeting potential challenges such as the 
immune response against the amount of algae.  
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new prospects for applications of 
microalgae in drug delivery.  
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